BIRC5 and cervical cancer: It is particularly notable that this study discovered for the first time in cervical cancer that EFE simultaneously affects 3 key pathological processes by regulating the AA metabolic network: regulating apoptosis through bcl-2/survivin, inhibiting proliferation through cyclin D1, and regulating the inflammatory microenvironment through NF-κB.